Protect your adolescent and young adult female patients’ fertility from the long-term effects of chlamydia and gonorrhea. Commit to opt-out, an enhanced screening strategy that the CDC recommends providers consider for all female patients ages 15-24.
| Recommended Laboratory Screening | Corresponding Quest Test | Test code(s) |
| Annual chlamydia and gonorrhea testing (under 25 and if sexually active and for older women who are at increased risk for infectiona) | Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital | 11363 |
Cervical Cancer Screening recommended to start at age 21: 1. In women 21–65 years of age: Cervical cytology (Pap) alone every 3 years (Reflex to HPV if Pap is ASC-US) 2. In women 30–65 years of age: Co-testing with Pap and HPV together every 5 years (preferred), or Pap alone every 3 years (Reflex to HPV if Pap is ASC-US) |
Image-Guided Pap with Age-Based Screening Protocolse | 91384 |
| Image-Guided Pap with Age-Based Screening with CT/NGe | 91385 | |
| Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonase | 91386 | |
| Pap alonee | See note below | |
| Human immunodeficiency virus (HIV) testingb | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesc | 91431 |
| Screening for trichomonas when risk factors are identifiedd | SureSwab®, Trichomonas vaginalis RNA, Qualitative, TMA | 19550 |
A recent Quest Diagnostics Health Trends™ unprecedented 8-year data analysis of 13.6 million women between the ages of 30 and 65 across the US confirmed that more cases of cervical cancer were identified with co-testing than with HPV or Pap testing alone.
For patients with a family or personal history of breast or ovarian cancer, Ashkenazi Jewish ancestry, or other potential heritable conditions, genetic testing can provide valuable information to help inform the best treatment decisions. Our hereditary cancer screening is performed on a next-generation sequencing platform in conjunction with our proprietary software to allow for the most accurate identification of disease.
| Recommended Laboratory Screening | Corresponding Quest Test | Test code(s) |
| Annual mammography | N/A | N/A |
| Diabetes testing every 3 years after age 45 | Glucose | 483 |
| Hemoglobin A1c | 496 | |
| Cardio IQ® Diabetes Risk Panel with Scoref | 92026 | |
| Diabetes Rick Panel with Score | 92027 | |
| Cardio IQ® Insulin Resistance Panel with Score | 36509 | |
Cervical Cancer Screening Co-testing with Pap and HPV together every 5 years (preferred) |
Image-Guided Pap with Age-Based Screening Protocolse | 91384 |
| Image-Guided Pap with Age-Based Screening with CT/NGe | 91385 | |
| Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonasee | 91386 | |
| Pap alonee | See note below | |
| Lipid profile assessment every 5 years beginning at age 45 | Lipid Panel, Standard | 7600 |
| Cardio IQ® ASCVD Risk Panel with Scoref | 92052 | |
| ASCVD Risk Panel with Score | 92053 | |
| Advanced Lipid Panel with Inflammation, Cardio IQ® | 94220 | |
| Thyroid-stimulating hormone testing every 5 years beginning at age 50 | TSH | 899 |
| TSH with Reflex to Free T4 | 36127 | |
| Thyroid Panel with TSH | 7444 | |
| Colorectal cancer screening with colonoscopy every 10 years beginning at age 50 or at age 45 for African-American women (preferred); fecal immunochemical test (FIT) annually starting at age 50 as an alternative to colonoscopy | Fecal Globin by Immunochemistry (InSure®) | 11290 |
| Human immunodeficiency virus (HIV) testingb | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesc | 91431 |
| One-time hepatitis C testing for persons born from 1945 through 1965 and unaware of their infection status (more often for high-risk patients) | Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR | 8472 |
| Screening for chlamydia, gonorrhea, and trichomonas (when risk factors are identifiedd) | Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital | 11363 |
| SureSwab®, Trichomonas vaginalis RNA, Qualitative, TMA | 19550 |
Quest evaluates more Pap tests than any other lab, while still maintaining the highest of quality standards. We help ensure reliable results through an extensive algorithm of laboratory accuracy checks, and our quality control process meets or exceeds all state and federal requirements.
a Positive results may need to be reported to the authorities under applicable law. Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit acog.org and search for Well-Woman Recommendations.
b Healthcare providers should always follow state HIV screening requirements. For more information, visit www.cdc.gov and search for the September 22, 2006 issue of MMWR™ Recommendations and Reports.
c Reflex testing may be performed at an additional charge.
d The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection.
e The age-based (Smart Codes) offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG guidelines do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the guidelines. Non-imaged Paps, conventional Paps, as well as additional testing recommended by the guidelines, may be ordered individually and are available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory or go to QuestDiagnostics.com/TestDirectory for more information.
f To learn more about our Cardio IQ testing, visit QuestDiagnostics.com/CardioIQ.
Test codes may vary by location. Please contact your local laboratory for more information.
References:
Review the latest data from our new 2020 Health Trends™ study.
Stay up-to-date on the latest COVID-19-related guidelines published by key women’s health organizations.
With rates of sexually transmitted infections (STIs) on the rise, assessing women who may be high-risk is more important than ever.
Contact us to receive additional information on our lab tests, services, and coverage
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
